• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Sarepta Therapeutics Inc

+ Add to Watchlist

AB3A:GR

11.005 EUR 0.014 0.13%

As of 13:36:06 ET on 12/19/2014.

Snapshot for Sarepta Therapeutics Inc (AB3A)

Open: 11.134 Day's Range: 10.897 - 11.134 Volume: 0
Previous Close: 11.019 52wk Range: 9.980 - 28.439 1-Yr Rtn: -24.10%

Stock Chart for AB3A

No chart data available.
  • AB3A:GR 11.132
  • 1D
  • 1M
  • 1Y
11.019
Interactive AB3A Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AB3A

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -2.8870
Est. PEG Ratio -
Market Cap (M EUR) 454.62
Shares Outstanding (M) 41.31
30 Day Average Volume 280
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AB3A

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AB3A

Sarepta Therapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of unique RNA-based therapeutics for the treatment of both rare and infectious diseases. The Company offers its products to the medical industry in countries around the world.

John HodgmanInterim ChairmanChristopher N GarabedianPresident/CEO
Sandesh Mahatme "Sandy"Senior VP/CFO/Chief Acctg OfcrEdward M KayeSenior VP/Chief Medical Officer
More Company Profile & Key Executives for AB3A

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil